IP Library › Granted Patent US 8,343,920
Granted Patent B2
US 8,343,920 · App. 13/169,722 · Granted Jan 1, 2013

Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds

Assignee: Stem Cell Therapeutics Corp.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,343,920
App. No.
13/169,722
Granted
Jan 1, 2013
Kind
B2
Abstract

The present invention provides for a method for stimulating the proliferation of pluripotential stem cells in a mammal comprising administration of pregnancy related compounds more particularly human chorionic gonadotropin, leutenizing hormone or prolactin. The present invention further provides for a method of treatment of tissues or organs experiencing cellular damage, injury or disease.

Claims (3)

1. A method to increase proliferation of cells in the heart of a patient in need thereof comprising administering to said patient an HCG or an LH, wherein the patient has a disease, condition, or injury that has caused loss or death of cells in the heart of the patient.

2. A method of treating a human with a disease or condition that has caused loss or death of cells in the heart of the human comprising administration of an HCG or an LH to the human.

3. The method of claim 2 , wherein LH is administered to the human.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2012
From: TUCKER, JOSEPH
To: STEM CELL THERAPEUTICS CORP.
Reel/Frame 029361/0839 →
Continuity (4)
Division 11246511 · Oct 7, 2005
Provisional Application 60661255 · Mar 10, 2005
Provisional Application 60616204 · Oct 7, 2004
Related Publication 20120071404A1 · Mar 22, 2012